BH3-MIMETIC TREATMENT REVEALS SUBTYPE-SPECIFIC BCL-2 PROTEIN DEPENDENCY IN PEDIATRIC MDS WITH EXCESS BLASTSSheila Bohler, Miriam Erlacher, Nastassja K. Scheidegger et al.|EJC Paediatric Oncology|2025Cited by 0